Agrimony

a clinical trial on 80 people showed it lowered liver enzymes and protected against liver injury. it kills hepatitis B antigen, prevents blood clots through the intrinsic coagulation pathway, and selectively kills cancer cells without touching normal ones. the antimicrobial activity against vancomycin-resistant bacteria is clinically relevant. wound healing is mechanically validated at the cellular level. most people know it as a gentle digestive tea.

quercetin, luteolin, and the ellagitannins all independently suppress pro-inflammatory cytokine production. isofraxidin-like activity through COX inhibition adds to the combined anti-inflammatory picture.

agrimony contributes to epithelial regeneration, neovascularization, and matrix remodeling during wound healing. acts synergistically with TGF-β1 to promote myofibroblast-like phenotype transition — the cells responsible for wound contraction and closure.

the tannin agrimoniin and the flavonoids luteolin and quercetin are the most studied cytotoxic compounds from this plant, with activity against multiple cancer lines including colon, breast, and cervical cancer cells.

herb extracts inhibit thrombus formation and the intrinsic coagulation pathway, the intrinsic pathway (Factor XII cascade) is one of two primary routes through which blood clots form. inhibiting it reduces pathological clotting risk without completely abolishing coagulation.

intestinal extracts inhibit α-glucosidase, consequently slowing glucose absorption.